Pregabalin Capsule
Product Images NDC 71610-765

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 71610-765). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 75 mg (71610 0765 30)

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Figure 1 (Pregabalincaps Fig01)

FDA Label Image

Figure 2 (Pregabalincaps Fig02)

FDA Label Image

Figure 3 (Pregabalincaps Fig03)

FDA Label Image

Figure 4 (Pregabalincaps Fig04)

FDA Label Image

Figure 5 (Pregabalincaps Fig05)

FDA Label Image

Figure 6 (Pregabalincaps Fig06)

FDA Label Image

Figure 7 (Pregabalincaps Fig07)

FDA Label Image

Figure 8 (Pregabalincaps Fig08)

FDA Label Image

Figure 9 (Pregabalincaps Fig09)

Figure 9 (Pregabalincaps Fig09)
This text appears to be a table showing the estimated percentage of subjects without LTR (Long Term Relief) for a certain study. The table includes percentages ranging from 100% to 0%, spaced at intervals of 10%. The table also mentions two groups: "Progabain" and "Placebo". The numbers "20", "40", "80", and "120" are listed horizontally beneath the headings "Days". It is unclear what exactly these numbers signify without additional context.*
FDA Label Image

Figure 11 (Pregabalincaps Fig10)

FDA Label Image

Figure 12 (Pregabalincaps Fig11)

Figure 12 (Pregabalincaps Fig11)
This text provides information on the percent of subjects improved over a period of time. The data shows a range of values from 100 to 280, with specific values at 210, 220, 230, 240, 250, 260, and 270. It also mentions the comparison between Pregabalin and Placebo. However, without further context or additional information, it is difficult to interpret the significance of these numbers.*
FDA Label Image

Cockcroft And Gault Equation (Pregabalincaps Formula)

Cockcroft And Gault Equation (Pregabalincaps Formula)
This text appears to be an equation for calculating CLCT (Clearance of Creatinine) in patients. It involves variables such as age, weight, and serum creatinine levels. However, the output is not completely clear and contains non-English characters. Therefore, the information is not available.*
FDA Label Image

Chemical Structure (Pregabalincaps Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.